Back
Also listed as
SEMHF
OTC
Day Range
$21.11
$21.50
52-Week Range
$20.85
$28.92
Volume
11,980
50D / 200D Avg
$24.54
/
$26.27
Prev Close
$20.91
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 47.6 | 0.4 |
| P/B | 4.5 | 2.9 |
| ROE % | 10.3 | 3.7 |
| Net Margin % | 9.2 | 3.8 |
| Rev Growth 5Y % | 5.2 | 10.0 |
| D/E | 0.8 | 0.2 |
Key Takeaways
Revenue grew 5.19% annually over 5 years — modest growth
ROE of 10.26% — decent returns on equity
Generating 2.14B in free cash flow
P/E of 47.59 — premium valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 6.67%
Cash machine — converts 105.64% of earnings into free cash flow
Growth
Revenue Growth (5Y)
5.19%
Revenue (1Y)-1.48%
Earnings (1Y)4.07%
FCF Growth (3Y)48.28%
Quality
Return on Equity
10.26%
ROIC6.24%
Net Margin9.17%
Op. Margin14.70%
Safety
Debt / Equity
0.83
Current Ratio1.11
Interest Coverage8.08
Valuation
P/E Ratio
47.59
P/B Ratio4.54
EV/EBITDA34.50
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -1.48% | Revenue Growth (3Y) | 0.81% |
| Earnings Growth (1Y) | 4.07% | Earnings Growth (3Y) | 15.73% |
| Revenue Growth (5Y) | 5.19% | Earnings Growth (5Y) | 4.01% |
| Profitability | |||
| Revenue (TTM) | 22.03B | Net Income (TTM) | 2.02B |
| ROE | 10.26% | ROA | 3.88% |
| Gross Margin | 38.63% | Operating Margin | 14.70% |
| Net Margin | 9.17% | Free Cash Flow (TTM) | 2.14B |
| ROIC | 6.24% | FCF Growth (3Y) | 48.28% |
| Safety | |||
| Debt / Equity | 0.83 | Current Ratio | 1.11 |
| Interest Coverage | 8.08 | Dividend Yield | 0.02% |
| Valuation | |||
| P/E Ratio | 47.59 | P/B Ratio | 4.54 |
| P/S Ratio | 4.37 | PEG Ratio | 7.41 |
| EV/EBITDA | 34.50 | Dividend Yield | 0.02% |
| Market Cap | 96.18B | Enterprise Value | 111.71B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 22.03B | 22.36B | 21.68B | 21.71B | 18.00B |
| Net Income | 2.02B | 1.94B | 1.51B | 2.04B | 1.73B |
| EPS (Diluted) | 0.90 | 0.87 | 0.67 | 0.91 | 0.78 |
| Gross Profit | 8.51B | 8.47B | 7.71B | 8.14B | 6.95B |
| Operating Income | 3.24B | 3.30B | 2.44B | 3.06B | 2.78B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 52.13B | 46.06B | 46.68B | 49.06B | 41.93B |
| Total Liabilities | 30.88B | 27.81B | 28.55B | 29.20B | 25.87B |
| Shareholders' Equity | 21.20B | 18.20B | 18.08B | 19.84B | 16.04B |
| Total Debt | 17.70B | 16.21B | 16.65B | 16.65B | 14.32B |
| Cash & Equivalents | 2.18B | 2.68B | 1.64B | 1.44B | 1.32B |
| Current Assets | 16.57B | 14.44B | 14.14B | 13.38B | 10.78B |
| Current Liabilities | 14.86B | 11.57B | 13.44B | 12.02B | 10.11B |